Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
72 |
|
| Actual shortage: | 4 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 68 (94%) | |
Discontinuation Reports |
32 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 32 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
47 (45%) |
|
Overdue reports |
4 (100%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-NABILONE | 1MG | CAPSULE | Resolved | 2017-06-08 | 2019-02-01 | 12331 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-22 | 2018-08-21 | 30228 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-09-09 | 85347 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-27 | 2019-02-04 | 27316 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-20 | 2020-02-02 | 103678 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36060 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-02-02 | 2020-03-07 | 105127 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36063 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-08-19 | 85342 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2017-06-08 | 2018-08-23 | 12300 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2019-06-07 | 2020-08-28 | 85902 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2019-06-24 | 2020-08-28 | 87388 |
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2017-06-08 | 2018-08-23 | 12310 |
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2019-07-05 | 2020-08-28 | 88746 |
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2019-09-23 | 2020-08-28 | 94548 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-07-18 | 2018-08-23 | 16331 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-02-15 | 2020-10-28 | 75900 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132979 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Actual shortage | 2022-04-12 | 2023-08-16 | 158553 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2017-10-27 | 2018-08-23 | 27310 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2017-07-21 | 2017-07-21 | 16605 |
| RAN-NABILONE | 0.25MG | CAPSULE | Discontinued | 2018-02-02 | 2018-02-03 | 38216 |
| RAN-NABILONE | 0.5MG | CAPSULE | Discontinued | 2018-02-02 | 2018-02-03 | 38219 |
| RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2018-02-02 | 2018-02-03 | 38224 |
| RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50986 |
| RAN-NABILONE | 0.25MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50989 |
| RAN-NABILONE | 0.5MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50992 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91278 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91281 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-02-02 | 2020-02-02 | 105096 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-03-07 | 2020-03-07 | 108130 |
| RAN-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-21 | 2017-07-21 | 16588 |